Skip to main content
. 2016 Jul 18;66(9):1677–1687. doi: 10.1136/gutjnl-2015-311166

Table 3.

Receiver operating characteristic (ROC) curve analysis of pancreatic juice mutation concentrations (overall 115#)

KRAS only GNAS only TP53 only TP53+SMAD4 All 9 genes
PDAC vs controls AUC 0.74 0.61 0.79 0.82 0.89
95% CI of AUC 0.62 to 0.87 0.46 to 0.76 0.68 to 0.91 0.72 to 0.93 0.80 to 0.97
Specificity 91.7% 83.4% 100.0% 100.0% 83.4%
Sensitivity 50.0% 38.2% 58.8% 64.7% 85.3%
p Value 0.002 0.174 0.0002 <0.0001 <0.0001
IPMN vs controls AUC 0.74 0.67 0.63 0.63 0.85
95% CI of AUC 0.62 to 0.85 0.55 to 0.80 0.51 to 0.76 0.51 to 0.76 0.76 to 0.93
Specificity 83.4% 83.4% 100.0% 100.0% 83.4%
Sensitivity 57.1% 51.8% 26.8% 26.8% 73.2%
p Value 0.001 0.015 0.058 0.058 <0.0001
PDAC vs IPMN AUC 0.56 0.56 0.69 0.73 0.69
95% CI of AUC 0.43 to 0.70 0.43 to 0.68 0.58 to 0.81 0.62 to 0.85 0.56 to 0.81
Specificity 42.9% 51.8% 73.2% 73.2% 85.7%
Sensitivity 52.9% 61.8% 58.8% 64.7% 52.9%
p Value 0.290 0.324 0.002 0.0002 0.003

AUC, area under the curve; IPMN, intraductal papillary mucinous neoplasm; PDAC, pancreatic ductal adenocarcinoma.